Epistem Announces a Three Year Collaboration with GlaxoSmithKline in Fibrosis Research

Epistem announces a three year biomarker collaboration with GlaxoSmithKline

in the field of fibrosis research. The collaboration will focus on identifying key characteristics of diseased fibrotic tissue on which Epistem will apply its proprietary RNA-Amp™ technology to facilitate building an in depth understanding of the disease.